New therapeutic approaches for type 2 diabetes
Submission Deadline: 31 Dec 2009
Guest Editors

Doctor, Metabolic diseases, 11 rue des Moulineaux, 92150 Suresnes, France
Interests: 19 publications, - grants, Editor of Frontiers in Bioscience

Metabolic diseases, 11 rue des Moulineaux, 92150 Suresnes, France
Interests: 19 publications, - grants, Editor of Frontiers in Bioscience
Keywords
- Endocrine System
- Molecular Biology
- Technology
- Therapeutics
Published Papers (8)
The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases?
Front. Biosci. (Landmark Ed) 2009, 14(13), 5107–5117; https://doi.org/10.2741/3589
(This article belongs to the Special Issue New therapeutic approaches for type 2 diabetes)
Pharmacogenetics and future strategies in treating hyperglycaemia in diabetes
Front. Biosci. (Landmark Ed) 2009, 14(11), 4348–4362; https://doi.org/10.2741/3532
(This article belongs to the Special Issue New therapeutic approaches for type 2 diabetes)
Targeting the AMPK pathway for the treatment of Type 2 diabetes
Front. Biosci. (Landmark Ed) 2009, 14(9), 3380–3400; https://doi.org/10.2741/3460
(This article belongs to the Special Issue New therapeutic approaches for type 2 diabetes)
Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes
Front. Biosci. (Landmark Ed) 2009, 14(8), 2983–2995; https://doi.org/10.2741/3428
(This article belongs to the Special Issue New therapeutic approaches for type 2 diabetes)
Therapeutic approaches based on beta-cell mass preservation and/or regeneration
Front. Biosci. (Landmark Ed) 2009, 14(5), 1835–1850; https://doi.org/10.2741/3345
(This article belongs to the Special Issue New therapeutic approaches for type 2 diabetes)
Current strategies for the inhibition of hepatic glucose production in type 2 diabetes
Front. Biosci. (Landmark Ed) 2009, 14(3), 1169–1181; https://doi.org/10.2741/3301
(This article belongs to the Special Issue New therapeutic approaches for type 2 diabetes)
Failure of beta-cell adaptation in type 2 diabetes: Lessons from animal models
Front. Biosci. (Landmark Ed) 2009, 14(3), 1099–1115; https://doi.org/10.2741/3296
(This article belongs to the Special Issue New therapeutic approaches for type 2 diabetes)
The implication of proinflammatory cytokines in type 2 diabetes
Front. Biosci. (Landmark Ed) 2008, 13(13), 5187–5194; https://doi.org/10.2741/3074
(This article belongs to the Special Issue New therapeutic approaches for type 2 diabetes)
